ID
44723
Description
TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects; ODM derived from: https://clinicaltrials.gov/show/NCT02276430
Lien
https://clinicaltrials.gov/show/NCT02276430
Mots-clés
Versions (1)
- 28/09/2021 28/09/2021 -
Détendeur de droits
University Medical Center Groningen The Netherlands Cancer Institute
Téléchargé le
28 septembre 2021
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Testicular Cancer NCT02276430
Eligibility Testicular Cancer NCT02276430
- StudyEvent: Eligibility
Description
in order to be eligible to participate in the cardiometabolic risk inventory study (and to be invited to a study assessment), a subject must meet, next to the criteria mentioned in "1)", the following inclusion criteria:
Alias
- UMLS CUI [1]
- C1512693
Description
Age at the tc diagnosis
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0153594
- UMLS CUI [1,2]
- C1828181
Description
Age at the moment of inclusion
Type de données
boolean
Alias
- UMLS CUI [1,1]
- C0001779
- UMLS CUI [1,2]
- C1512693
- UMLS CUI [1,3]
- C0681850
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Similar models
Eligibility Testicular Cancer NCT02276430
- StudyEvent: Eligibility
C2316983 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,2])
C1301943 (UMLS CUI [1,3])
C1828181 (UMLS CUI [1,2])
C1956346 (UMLS CUI [2,1])
C2985911 (UMLS CUI [2,2])
C0018802 (UMLS CUI [3,1])
C2985911 (UMLS CUI [3,2])
C0262926 (UMLS CUI [1,2])
C0153594 (UMLS CUI [1,3])
C0332152 (UMLS CUI [1,4])
C0332197 (UMLS CUI [1,5])
C1828181 (UMLS CUI [1,2])
C1512693 (UMLS CUI [1,2])
C0681850 (UMLS CUI [1,3])
C0205177 (UMLS CUI [1,2])